Grant Thornton teams with Gens & Associates to advance life sciences regulatory innovation and compliance


Firm joins Gens’ Benchmark Premier program as part of strategic alliance


Washington Crossing, Pa. — Grant Thornton LLP and Gens & Associates are working closely to advance regulatory compliance, innovation and transformation initiatives for life sciences organizations.

Gens & Associates is a life sciences benchmarking and management consultancy that provides regulatory information management (RIM) research, including the industry’s most comprehensive regulatory benchmarking survey to more than 100 global pharmaceutical, medical device, consumer and generic drug companies.

Organizations depend on its research to improve efficiency, reduce information management complexity and understand what practices translate into strong regulatory operational performance. Gens & Associates provides the regulatory community with trusted and independent peer benchmarks, along with a detailed view and perspective of the provider landscape.

Grant Thornton joins the Benchmark Premier program as part of a strategic alliance with Gens & Associates. The firm will work collaboratively with Gens & Associates to help organizations address complexities like regulatory cost pressures, compliance with evolving standards, fragmented regulatory systems and quickening time to market.

“As the industry evolves, life sciences organizations are recognizing the importance of RIM as an enterprise capability that affects compliance, productivity and time to market,” said John Cassimatis, managing director and Business Consulting Life Sciences leader for Grant Thornton. “Gens & Associates provides those RIM insights – and Grant Thornton brings industry and regulatory management consulting experience. This powerful combination will help organizations transform their regulatory operations and accelerate the benefits realization of their regulatory change initiatives.”

Along with the firm’s existing life sciences consulting capabilities, the arrangement expands Grant Thornton’s reach and offerings for industry clients. Grant Thornton brings to Gens & Associates new prospective survey participants and the experience and capabilities to help organizations meet their regulatory compliance, innovation and transformation goals.

“Our mission is to help all stakeholders in the regulatory ecosystem improve their performance through our research platform,” said Steve Gens, managing partner of Gens & Associates. “Our Benchmark Premier program and strategic alliance with Grant Thornton allow us to expand our benchmarking capability and assist more organizations.”

For more information about how Grant Thornton serves life sciences organizations, visit

About Gens & Associates
Gens & Associates is a boutique life sciences management and organizational consultancy that specializes in strategic planning, industry benchmarking, regulatory information management and organizational transition management.

Founded in 2005, its mission is to help all stakeholders in the regulatory ecosystem accelerate global transformation, increase efficiency and organizational agility to shorten approvals of effective new drugs and contribute to medicine affordability.



About Grant Thornton LLP


Founded in Chicago in 1924, Grant Thornton LLP (Grant Thornton) is the U.S. member firm of Grant Thornton International Ltd, one of the world’s leading organizations of independent audit, tax and advisory firms. Grant Thornton, which has revenues of $1.97 billion and operates more than 50 offices, works with a broad range of dynamic publicly and privately held companies, government agencies, financial institutions, and civic and religious organizations.


“Grant Thornton” refers to Grant Thornton LLP, the U.S. member firm of Grant Thornton International Ltd (GTIL). GTIL and the member firms are not a worldwide partnership. Services are delivered by the member firms. GTIL and its member firms are not agents of, and do not obligate, one another and are not liable for one another’s acts or omissions.






More press releases